Search research articles
Contact Us
Filters
Showing results (101-110 of 137) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2016
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling
Heather L McArthur, Adi Diab, David B Page, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma
Caitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
The Journal of Clinical Investigation
|
May 13, 2022
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade
Amber Hickman, Joost Koetsier, Trevin Kurtanich, et al.
Nature Communications
|
February 2, 2020
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
Meenu Sharma, Hiep Khong, Faisal Fa'ak, et al.
Frontiers in Oncology
|
November 3, 2022
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
Joel Ho, Jane Mattei, Michael Tetzlaff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff, et al.
Cancer Immunology Research
|
October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
James W Welsh, Chad Tang, Patricia de Groot, et al.
Journal for Immunotherapy of Cancer
|
June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
Faisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 8, 2021
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
Roshal R Patel, Kewen He, Hampartsoum B Barsoumian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2020
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma
Lauren E Haydu, Serigne N Lo, Jennifer L McQuade, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 137) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2016
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling
Heather L McArthur, Adi Diab, David B Page, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma
Caitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
The Journal of Clinical Investigation
|
May 13, 2022
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade
Amber Hickman, Joost Koetsier, Trevin Kurtanich, et al.
Nature Communications
|
February 2, 2020
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
Meenu Sharma, Hiep Khong, Faisal Fa'ak, et al.
Frontiers in Oncology
|
November 3, 2022
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
Joel Ho, Jane Mattei, Michael Tetzlaff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff, et al.
Cancer Immunology Research
|
October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
James W Welsh, Chad Tang, Patricia de Groot, et al.
Journal for Immunotherapy of Cancer
|
June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
Faisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 8, 2021
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
Roshal R Patel, Kewen He, Hampartsoum B Barsoumian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2020
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma
Lauren E Haydu, Serigne N Lo, Jennifer L McQuade, et al.
Page
of 14